We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.15B
1-Year Est. Return 13.14%
This Fund
S&P 500
This Quarter Est. Return
-11.25%
1 Year Est. Return
+13.14%
3 Year Est. Return
+63.19%
5 Year Est. Return
+70.18%
10 Year Est. Return
+417.82%
AUM
$7.17B
AUM Growth
-$1.2B
Cap. Flow
-$130M
Cap. Flow %
-1.82%
Top 10 Hldgs %
74.07%
Holding
91
New
10
Increased
15
Reduced
26
Closed
6

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$31.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.9M
3
HD icon
Home Depot
HD
+$18.9M
4
AMZN icon
Amazon
AMZN
+$18.8M
5
MSFT icon
Microsoft
MSFT
+$18.1M

Sector Composition

Rank Sector Weight
1 Financials 22.24%
2 Consumer Discretionary 19.17%
3 Healthcare 13.86%
4 Consumer Staples 11.18%
5 Technology 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$130B
$20.8M 0.29%
125,811
HUM icon
27
Humana
HUM
$49.2B
$20.4M 0.28%
65,000
+10,000
+18% +$3.37M
DXCM icon
28
DexCom
DXCM
$31.3B
$19.5M 0.27%
290,212
-122,336
-30% -$7.61M
EXAS
29
DELISTED
Exact Sciences
EXAS
$19.4M 0.27%
334,630
+155,698
+87% +$12.6M
WY icon
30
Weyerhaeuser
WY
$15.9B
$18.4M 0.26%
1,086,829
EW icon
31
Edwards Lifesciences
EW
$48.6B
$18.1M 0.25%
287,241
MRK icon
32
Merck
MRK
$355B
$17.4M 0.24%
237,611
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$131B
$16.3M 0.23%
68,557
ILMN icon
34
Illumina
ILMN
$31.2B
$15.8M 0.22%
59,601
TFX icon
35
Teleflex
TFX
$5.55B
$15.5M 0.22%
53,000
CHRS icon
36
Coherus Oncology
CHRS
$205M
$14.7M 0.21%
908,464
+100,000
+12% +$1.85M
SRPT icon
37
Sarepta Therapeutics
SRPT
$2.16B
$14.2M 0.2%
145,329
TAL icon
38
TAL Education Group
TAL
$6.55B
$14.1M 0.2%
+265,075
New +$14.3M
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$12.7B
$13.8M 0.19%
163,851
LHCG
40
DELISTED
LHC Group LLC
LHCG
$13.4M 0.19%
95,657
EDU icon
41
New Oriental
EDU
$8.88B
$13.2M 0.18%
+122,006
New +$15.7M
PODD icon
42
Insulet
PODD
$9.15B
$12.1M 0.17%
72,908
+15,000
+26% +$2.74M
NVCR icon
43
NovoCure
NVCR
$1.81B
$11.2M 0.16%
166,784
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.6M 0.15%
311,751
TVRD
45
Tvardi Therapeutics
TVRD
$24.9M
$9.29M 0.13%
19,541
HRTX icon
46
Heron Therapeutics
HRTX
$59.9M
$8.24M 0.12%
702,069
GWPH
47
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.19M 0.11%
93,473
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
$7.51M 0.1%
556,142
INSM icon
49
Insmed
INSM
$28.3B
$7.1M 0.1%
443,110
AXNX
50
DELISTED
Axonics, Inc. Common Stock
AXNX
$6.86M 0.1%
+270,000
New +$8.03M

Similar funds

C WorldWide Group's Q1 2020 Portfolio in Review

As of Q1 2020, C WorldWide Group held 91 positions worth $7.17B, down 14% from $8.37B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group's Q1 2020 filing shows 10 new, 15 increased, 26 reduced and 6 closed positions. Its largest new stake was Sea Limited: 841,323 shares worth $37.3M. The largest sale was Visa, an estimated $31.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q1 2020 buy was Sea Limited: 841,323 shares worth $37.3M.
  • C WorldWide Group added most to Exact Sciences in Q1 2020, an estimated $12.6M increase.
  • C WorldWide Group's biggest Q1 2020 reduction was Visa, cutting an estimated $31.3M.
  • C WorldWide Group fully exited Teladoc Health in Q1 2020, selling an estimated $16.3M.
  • C WorldWide Group's ten largest holdings make up 74% of its $7.17B portfolio in Q1 2020.
  • C WorldWide Group opened 10 new positions and closed 6 in Q1 2020.
  • C WorldWide Group's portfolio value fell 14% quarter-over-quarter to $7.17B.

Based on C WorldWide Group's 13F filing for Q1 2020, filed 4 May 2020.